CIK: 0001710065 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 12, 2021
Total Value ($000): $265,104 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVIR | ATEA PHARMACEUTICALS INC | 2,049,331 | $126,546 | 47.7% | $32.23 | +109.6% | COM | 04683R106 |
| SEER | SEER INC | 1,066,375 | $53,340 | 20.1% | $63.62 | -8.0% | COM CL A | 81578P106 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,114,962 | $47,843 | 18.0% | $42.30 | +11.9% | COM | 03753U106 |
| KYMR | KYMERA THERAPEUTICS INC | 639,059 | $24,834 | 9.4% | $48.78 | +23.4% | COM | 501575104 |
| — | SUTRO BIOPHARMA | 175,000 | $3,983 | 1.5% | $21.71 | — | COM | 869367102 |
| — | MOLECULAR TEMPLATES INC | 204,809 | $2,585 | 1.0% | $9.39 | — | COM | 608550109 |
| — | RAPT THERAPEUTICS INC | 108,503 | $2,409 | 0.9% | $19.75 | — | COM | 75382E109 |
| — | CLEARSIDE BIOMEDICAL INC | 793,555 | $1,960 | 0.7% | $2.74 | — | COM | 185063104 |
| — | KEZAR LIFE SCIENCES INC | 128,916 | $768 | 0.3% | $5.22 | — | COM | 49372L100 |
| — | AILERON THERAPEUTICS INC | 517,558 | $740 | 0.3% | $1.04 | — | COM | 00887A105 |
| — | BELLICUM PHARMACEUTICALS INC | 25,651 | $96 | 0.0% | $3.55 | — | COM NEW | 079481404 |